Package Leaflet: Information for the User
Paliperidona Alter 3 mg prolonged-release tablets EFG
Paliperidona Alter 6 mg prolonged-release tablets EFG
Paliperidona Alter 9 mg prolonged-release tablets EFG
Read the entire package leaflet carefully before starting to take this medication because it contains important information for you.
Contents of the Package Leaflet
Paliperidona contains the active substance paliperidona, which belongs to the class of antipsychotic medications.
Paliperidona is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms such as hearing, seeing, or feeling things that do not exist, having false beliefs, having more than normal distrust, being withdrawn, speaking incoherently, and planning behavior and emotionality. People with this disorder may also feel depressed, anxious, guilty, or tense.
Paliperidona is also used to treat schizoaffective disorder in adults.
Schizoaffective disorder is a mental condition where a person experiences various symptoms of schizophrenia (listed in the previous paragraph) in addition to mood disorder symptoms (feelings of euphoria, sadness, agitation, distraction, insomnia, verbosity, loss of interest in daily activities, excessive or insufficient sleep, excessive or insufficient food intake, and recurring thoughts of suicide).
Paliperidona may help alleviate the symptoms of your illness and prevent them from recurring.
Do not takepaliperidona
Warnings andprecautions
Consult your doctor, pharmacist, or nurse before starting to take paliperidona.
Controlled by a possible change of symptoms.
You should know that these two disorders can be caused by this type of medication.
Caused by other medications.
If you have any of these diseases, please consult your doctor, as it may be necessary to adjust your dose or keep you under observation for a while.
Because it has been rarely observed in patients treated with paliperidona a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check the number of white blood cells.
Paliperidona may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
In patients treated with paliperidona, diabetes mellitus or worsening of pre-existing diabetes mellitus has been observed, and your doctor should check for signs of increased blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not increase in size as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery, which can cause eye damage. If you are considering eye surgery, make sure to inform your ophthalmologist that you are using this medication.
Children andadolescentes
Paliperidona should not be administered to children and adolescents under 15 years of age for the treatment of schizophrenia.
Paliperidona should not be administered to children and adolescents under 18 years of age for the treatment of schizoaffective disorder.
This is because it is unknown whether paliperidona is safe or effective in this age group.
Othermedicaments and paliperidona
Tell your doctor or pharmacist if you are using or have recently used other medications.
Anomalies in heart function may appear when taking this medication with other medications for heart rhythm control or other medications such as antihistamines, antimalarials, or antipsychotics.
Since this medication acts mainly on the brain, it may interfere with other medications (or alcohol) that also act on it, due to the sum of effects on brain function.
This medication may reduce blood pressure, so you should be careful if you take this medication with other medications that also reduce it.
This medication may reduce the effect of medications for Parkinson's disease and restless legs syndrome (e.g., levodopa).
The effects of this medication may be affected if you take medications that influence the speed of intestinal movement (e.g., metoclopramide).
A reduction in the dose of this medication should be considered when administered with valproate.
The use of oral risperidone with this medication is not recommended, as this combination may cause an increase in side effects.
Taking paliperidona withalcohol
You should avoid consuming alcohol during treatment with this medication.
Pregnancy andlactation
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
You should not take this medication during pregnancy unless you have discussed it with your doctor.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidona in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your baby develops any of these symptoms, you should contact your doctor.
You should not take this medication during breastfeeding.
Driving and usingmachines
During treatment with this medication, dizziness and vision problems may occur (see section 4, possible side effects). This should be taken into account when maximum attention is required, for example, when driving or operating machinery.
Paliperidona Alter contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor, pharmacist, or nurse.
Use inadults
The recommended dose in adults is 6 mg once daily in the morning. Your doctor may increase or decrease it within the dosage range of 3 mg to 12 mg once daily in case of schizophrenia or 6 mg to 12 mg once daily in case of schizoaffective disorder. This depends on how well the medication works for you.
Use inadolescentes
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years and older is 3 mg once daily in the morning.
For adolescents who weigh 51 kg or more, the dose may be increased within the range of 6 mg to 12 mg once daily.
For adolescents who weigh less than 51 kg, the dose may be increased to 6 mg once daily.
Your doctor will decide how much to administer. The amount you take depends on how well the medication works for you.
How and when to take paliperidona
This medication should be taken orally, swallowed whole with water or other liquids. It should not be chewed, broken, or crushed.
This medication should be taken in the mornings with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication one day with breakfast and the next day on an empty stomach.
The active substance, paliperidona, dissolves once swallowed, and the tablet coating is eliminated from the body through the feces.
Patient with kidney problems
Your doctor may adjust the dose of this medication according to your renal function.
Elderly patients
Your doctor may reduce your dose of medication if your renal function is reduced.
If you take more paliperidona than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicology Information Service. Phone: 91 562 04 20, indicating the medication and the amount ingested. You may experience drowsiness, fatigue, abnormal body movements, problems standing and walking, dizziness due to low blood pressure, and cardiac arrhythmias.
If you forget to take paliperidona
Do not take a double dose to make up for forgotten doses. If you forget a dose, take the next dose the following day. If you forget two or more doses, contact your doctor.
If you stop treatment with paliperidona
Do not stop taking this medication, as you will lose the effects of the medication. You should not stop taking this medication unless your doctor tells you to, as the symptoms may recur.
If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Report immediately to your doctorif:
Very frequent: may affect more than 1 in 10 patients
inquietud
Frequent Adverse Effects: may affect up to 1 in 10 patients
Infrequent Adverse Effects: may affect up to 1 in 100 patients
Paliperidone may increase the levels of a hormone called "prolactin" that is detected in blood tests (which may or may not cause symptoms). When symptoms of increased prolactin appear, they may include: (in men) breast swelling, difficulty having or maintaining erections or other sexual dysfunctions, (in women) breast discomfort, milk secretion from the breasts, loss of menstrual periods or other problems with the cycle
Discinesia tardía (involuntary spasmodic movements that cannot be controlled in the face, tongue, or other parts of the body). Report to your doctor immediately if you experience involuntary rhythmic movements of the tongue, mouth, or face. Withdrawal of paliperidone may be necessary
Swelling of the tongue, stomach or intestinal infection, difficulty swallowing, excess gas or flatulence
Incontinence (loss of control) of urine, frequent urination, inability to pass urine, pain when urinating
Swelling of the face, mouth, eyes, or lips, swelling of the body, arms, or legs
Rare Adverse Effects: may affect up to 1 in 1,000 patients
Number of white blood cells in the blood dangerously low, necessary to fight infections
Intestinal obstruction, fecal incontinence, very hard stools, absence of intestinal movement that causes obstruction
Unknown frequency: cannot be estimated from available data
The following adverse effects have appeared with the use of another medicine called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone: sleep-related eating disorder, other types of cerebrovascular problems, and lung crackling sounds. Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medicine.
Additional Adverse Effects in Adolescents
Adolescents generally presented similar adverse effects to those found in adults, except for the following adverse effects that were detected more frequently:
Reporting of Adverse Effects
If you experience adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects that do not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton after CAD. The expiration date is the last day of the month indicated.
Blister packs: Store in the original packaging to protect it from moisture.
This medicine does not require any special storage temperature.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that you no longer need in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Paliperidona Alter
The active ingredient is paliperidone.
Each 3 mg prolonged-release tablet of Paliperidona Alter contains 3 mg of paliperidone.
Each 6 mg prolonged-release tablet of Paliperidona Alter contains 6 mg of paliperidone.
Each 9 mg prolonged-release tablet of Paliperidona Alter contains 9 mg of paliperidone.
The other components are:
Core
Macrogol 200,000, macrogol 700,000, butylhydroxytoluene, povidone K30, sodium chloride, microcrystalline cellulose PH102, magnesium stearate, red iron oxide (E172).
Intermediate tablet coating
Hydroxypropylcellulose
Semi-permeable coating
Cellulose acetate, macrogol 4000 Ph.Eur
Coating
Hypromellose 6CP, titanium dioxide, talc, propylene glycol, red iron oxide (E172) (for the 9 mg dose), yellow iron oxide (for the 6 mg dose)
Printing ink
Shellac, black iron oxide (E172).
Appearance of the Product and Package Contents
The 3 mg prolonged-release tablets of Paliperidona Alter are round, biconvex tablets with a white to grayish color and a possible irregular surface, printed with the mark P3 on one side of the tablet.
The 6 mg prolonged-release tablets of Paliperidona Alter are round, biconvex tablets with a yellowish-brown color and a possible irregular surface, printed with the mark P6 on one side of the tablet.
The 9 mg prolonged-release tablets of Paliperidona Alter are round, biconvex tablets with a pink color and a possible irregular surface, printed with the mark P9 on one side of the tablet.
The tablets are provided in blister packs packaged in cartons of 28 tablets.
Marketing Authorization Holder
Laboratorios Alter S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
Manufacturer
Krka, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
Date of the Last Revision of this Prospectus:July 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of PALIPERIDONE ALTER 3 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 27.58 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.